Production (Stage)
PMV Pharmaceuticals, Inc.
PMVP
$0.97
$0.022.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 160.39M | 169.45M | 182.84M | 212.92M | 197.94M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.11M | 6.20M | 5.96M | 5.05M | 3.70M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 822.00K | 822.00K | 822.00K |
| Total Current Assets | 163.50M | 175.66M | 189.62M | 218.79M | 202.46M |
|
|
|||||
| Total Current Assets | 163.50M | 175.66M | 189.62M | 218.79M | 202.46M |
| Net Property, Plant & Equipment | 1.44M | 1.55M | 18.54M | 18.57M | 19.11M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 237.00K | 235.00K | 242.00K | 182.00K | 182.00K |
| Total Assets | 170.61M | 191.29M | 223.50M | 237.54M | 236.88M |
|
|
|||||
| Total Accounts Payable | 3.59M | 6.58M | 2.06M | 4.53M | 859.00K |
| Total Accrued Expenses | 5.80M | 7.44M | 10.26M | 5.70M | 10.32M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 364.00K | 352.00K | 1.24M | 1.15M | 880.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 9.76M | 14.37M | 13.56M | 11.39M | 12.06M |
|
|
|||||
| Total Current Liabilities | 9.76M | 14.37M | 13.56M | 11.39M | 12.06M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 742.00K | 838.00K | 12.02M | 11.84M | 12.14M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 10.50M | 15.21M | 25.59M | 23.22M | 24.20M |
|
|
|||||
| Common Stock & APIC | 546.17M | 544.65M | 543.21M | 540.99M | 538.08M |
| Retained Earnings | -386.15M | -368.71M | -345.71M | -326.49M | -325.27M |
| Treasury Stock & Other | 84.00K | 139.00K | 410.00K | -185.00K | -129.00K |
| Total Common Equity | 160.11M | 176.08M | 197.91M | 214.32M | 212.68M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 160.11M | 176.08M | 197.91M | 214.32M | 212.68M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 160.11M | 176.08M | 197.91M | 214.32M | 212.68M |
|
|
|||||